Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
First-line drugs for hypertension
Cochrane Reviews, 07/14/09
Wright JM et al. - In this review health outcomes resulting from 4 drug classes are summarized. Most of the evidence demonstrated that first-line low-dose thiazides reduce mortality and morbidity (stroke, heart attack and heart failure). No other drug class improved health outcomes better than low-dose thiazides, and beta-blockers and high-dose thiazides were inferior. Low-dose thiazides should be the first choice drug in most patients with elevated blood pressure. Fortunately, thiazides are also very inexpensive.
Today in Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Homocysteine lowering interventions for preventing cardiovascular events
Cochrane Reviews, 10/19/09
Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09
Vitamin D and cardiovascular disease
Current Atherosclerosis Reports, 11/12/09
Today in Internal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Homocysteine lowering interventions for preventing cardiovascular events
Cochrane Reviews, 10/19/09
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


